Novabay Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NovaBay Pharmaceuticals aims to raise approximately $3.16 million through a public offering of common stock and warrants to fund working capital and general corporate purposes.
NovaBay Pharmaceuticals aims to raise capital through a public offering of common stock and warrants to support its eyecare and wound care product lines, including Avenova Spray.
NovaBay Pharmaceuticals is launching a public offering of common stock, pre-funded warrants, and accompanying Series F-1 and F-2 warrants to raise capital for working capital and general corporate purposes.
NovaBay Pharmaceuticals is seeking to raise capital through a public offering of common stock and warrants to fund its eyecare and wound care product lines, including its flagship Avenova Spray.
NovaBay Pharmaceuticals is registering the resale of up to 298,355 shares of its common stock by selling stockholders, issuable upon the exercise of warrants and conversion of unsecured convertible notes.